Genus (LON:GNS) Price Target Raised to GBX 3,300

Genus (LON:GNS) had its price target boosted by Deutsche Bank Aktiengesellschaft from GBX 3,100 to GBX 3,300 in a report published on Friday, MarketBeat.com reports. The firm currently has a buy rating on the stock.

Several other brokerages have also issued reports on GNS. Berenberg Bank increased their target price on Genus from GBX 3,050 to GBX 3,250 and gave the stock a “buy” rating in a research report on Friday. Shore Capital reaffirmed a “buy” rating and set a GBX 3,000 price target on shares of Genus in a report on Friday. Three research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of GBX 3,183.33.

Genus Price Performance

Genus stock remained flat at GBX 2,835 during trading on Friday. The company had a trading volume of 125,068 shares, compared to its average volume of 305,460. The firm has a market cap of £1.88 billion, a PE ratio of 98.10, a price-to-earnings-growth ratio of 2.87 and a beta of 0.37. The company’s 50-day moving average price is GBX 2,548.09 and its 200 day moving average price is GBX 2,517.50. The company has a debt-to-equity ratio of 53.12, a quick ratio of 1.08 and a current ratio of 1.80. Genus has a fifty-two week low of GBX 1,548 and a fifty-two week high of GBX 3,228.80.

Genus Company Profile

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.